Related Experiment Video
Updated: Jul 4, 2026

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients
Published on: March 1, 2024
Major recurrent aphthous ulceration: case report and review of the literature
1Internal Medicine Department, University of Connecticut Health Center, Farmington, USA. aboldo@resident.uchc.edu
Abstract:
A 25-year-old male presented complaining of a large painful ulcer near the left tonsil persisting for two months. Biopsy, serologies and cultures were performed to rule out infectious etiology. Symptomatic treatment was prescribed and the ulcer spontaneously resolved. One year later he presented with a similar ulcer, this time near the right tonsil, persisting for three months. A diagnosis of Major Recurrent Aphthous Ulceration was made based on the history and on the exclusion of other diagnoses. Prednisone 60 mg was prescribed and the ulcer healed in one week, leaving a scar. The case illustrates an unusual presentation of aphthous disease because of the ulcer's size and duration. Major recurrent aphthous ulcers constitute 10% to 15% of recurrent aphthous ulcers. These lesions are greater than 10 mm in diameter, take 10 to 30 days to heal. Categorized as an idiopathic disease, they are painful and recur with varying frequency. It is estimated that 20% of the general population will suffer from recurrent aphthous ulcer. The major variety differs because it lasts longer, often leaves a scar, and more frequently needs systemic medication. In this case, the lesion demonstrated a good response to steroids.
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Complications
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease II: Pathophysiology